We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. Read more about our Privacy Policy.

I got it!

Event
03 Apr 2017
Medicine

14th annual Controlled Release Delivery

Strengthening innovation and overcoming the challenging regulatory landscape

SMi is delighted to announce the return of the 14th annual Controlled Release Delivery conference taking place in London, UK on the 3rd and 4th of April 2017. Aimed at drug development experts and formulation specialists, Controlled Release Delivery 2017 will reflect on the latest innovations made within controlled release.

Drug delivery methods include oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable and transmucosal. With oral being the largest segment, controlled-release drug-delivery systems continue to play an important role in the treatment of diseases. 


With a carefully selected panel of industry experts, the 2017 event will address the latest regulatory updates and how to overcome challenges within the industry. Key topics that will be explored include: innovations in drug delivery, nanoparticles/nanomedicine & QbD, CNS drug delivery and therapeutic application.

SPEAKER LINE UP

CHAIRMEN:
•    Howard Stevens, Professor, University Of Strathclyde
•    Sudhakar Garad, Global Head of Chemical and Pharmaceutical Profiling,  Novartis Institutes for BioMedical Research

FEATURED SPEAKERS:

•    Markham Luke, Director, Division of Therapeutic Performance, FDA
•    René Holm, Head and Scientific Director, Liquids & Parenterals, Janssen
•    Mark Wilson, Director, Technology Licensing, PTS, GSK
•    Patrick Garidel, Associate Director Protein Science, Boehringer Ingelheim
•    Stephan Buchmann, Head Preformulation & Preclinical Galenics, Actelion
•    John Fox, Chief Executive Officer, Merrion Pharmaceuticals
•    and many more...


HIGHLIGHTS IN 2017:

•    Listen to FDA evaluate generic drug development
•    Novartis optimise the success of biopharmaceutical approaches for controlled release delivery
•    Can lipid suspensions improve oral bioavailability? Answers from Janssen
•    Insights into the opportunities and limitations to improving solubility and bioavailability with Actelion
•    Hear InnoCore Pharmaceuticals discuss microparticles and hydrogels for parenteral drug delivery

Early birds available
For details or to register, visit the website at www.controlledreleasedelivery.com/euageda or contact the team at +44(0) 207827 6000, email zgale@smi-online.co.uk 

When

3 Apr 2017 @ 08:00 am

4 Apr 2017 @ 05:00 pm

Duration: 1 days, 9 hours


Where

Copthorne Tara Hotel

1 Scarsdale Place

Kensington

United Kingdom


Language

English en


Organised by

SMi Group Ltd.

Other Events in Science

SLS&OPTIROB 2024

Romania, 27 Jun 2024

Similar Webinars in Science

MARIE CURIE ACTIONS Proposal Writing

Netherlands, , 26 Aug 2024

Recent Publications in Science

PASSENGER: a solution for futureproof permanent magnets made in Europe

Fact-sheet, Apr 2024, ESF - PASSENGER project